Drug shortages have been impacted by COVID-19, with 95% of doctors believing the pandemic exposed weaknesses in the medicine supply chain.

Kirk Garratt, MD, medical director of the Center for Heart and Vascular Health, ChristianaCare, and a past president of SCAI, explains what this shortage means for interventional cardiologists.

Terry Bowers, MD, director of vascular medicine at Beaumont Hospital and national co-chair of the Pulmonary Embolism Research Collaborative (PERC), explains the trend toward creating pulmonary embolism (PE) response teams that include cardiology. 

More than 1 million lives have been lost in the U.S. from COVID-19, according to the Centers for Disease Control and Prevention (CDC).

The American College of Cardiology (ACC), Association of Black Cardiologists, American Heart Association and Society for Cardiovascular Angiography & Interventions are just some of the healthcare organizations supporting the FDA's proposal.

Healthcare executives may need to do some creative thinking to manage the shrinking margins and labor shortages currently being seen throughout the industry. 

California-based health system Kaiser Permanente was slammed by a surge in COVID-19 cases during the first quarter of 2022, playing a role in a nearly $1 billion loss in the first three months of the year.

The move limits the vaccine to individuals 18 and older for whom other other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, as well as those 18 and older who would otherwise not receive a COVID-19 vaccine.